Skip to main content
. 2019 Nov;9(11):844–850. doi: 10.1542/hpeds.2019-0036

TABLE 3.

Comparison of Sociodemographics, Clinical Variables, and Secondary Outcomes for Caregivers With a Discharge Medication–Related Failure

Failure (n = 110) No Failure (n = 47) P
Independent variables
 Age, y, median (IQR) 3 (1.8 to 5.0) 3 (1.2 to 7.0) .93
 SES z score, median (IQR)a −3.5 (−7.0 to −1.6) −3.0 (−5.8 to −1.0) .26
 LOS, d, median (IQR) 1.9 (1.2 to 3.1) 2.3 (1.7 to 3.2) .06
 Sex of child, female, n (%) 50 (46) 26 (55) .26
Race and/or ethnicity, n (%) .03
 Hispanic 41 (37) 16 (34)
 Non-Hispanic African American 43 (39) 11 (23)
 Non-Hispanic other race 13 (12) 14 (30)
 Unavailable 13 (12) 6 (13)
Used hospital’s outpatient pharmacy, n (%) 60 (55) 28 (60) .56
No. eligible medications, n (%)b .28
 1 80 (73) 38 (81)
 2 23 (21) 5 (11)
 ≥3 7 (6) 4 (8)
Class of medication, n (%)b .79
 Steroid 37 (34) 13 (28)
 Antibiotic or antifungal 44 (40) 23 (49)
 Antiviral 17 (15) 6 (13)
 Other 12 (11) 5 (10)
APR-DRG of hospitalization, n (%)b .47
 Asthma 34 (31) 11 (23)
 Respiratory tract infection 38 (35) 13 (28)
 Gastrointestinal problem 7 (6) 3 (6)
 Genitourinary problem 3 (3) 4 (9)
 Skin and soft-tissue infection 6 (5) 3 (6)
 Other 22 (20) 13 (28)
Weekend discharge, n (%) 41 (37) 14 (30) .37
Secondary outcomes, n (%)
 AVS missing information 88 (82) 36 (77) .49
 Discrepant chartb 3 (3) 5 (11) .06
 Complex dosing 24 (22) 15 (32) .18

Total sample size: SES: 106 failures and 45 no failure; discrepant chart: 106 failures and 46 no failure; AVS missing information: 108 failures and 47 no failure. APR-DRG, All Patient Refined Diagnosis Related Group; IQR, interquartile range; LOS, length of stay; —, not applicable.

a

SES was reported as a z score calculated from small census tract data based on the patient’s home address; it reveals the deviation from the mean of the New York State population.31

b

Fisher’s exact test was used.